Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinities

M. P. Domogalla; S. U. Frick; G. Baier; F. Wurm; V. Mailaender; K. Landfester; K. Steinbrink

doi:10.1111/exd.12952

Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinities

M. P. Domogalla, S. U. Frick, G. Baier, F. Wurm, V. Mailaender, K. Landfester, K. Steinbrink

Research output: Contribution to journal › Conference article › Academic › peer-review

Original language	English
Article number	P140
Pages (from-to)	E24
Journal	Experimental dermatology
Volume	25
Issue number	3
DOIs	https://doi.org/10.1111/exd.12952
Publication status	Published - Mar 2016
Externally published	Yes

Access to Document

10.1111/exd.12952

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000373072800141&KeyUID=WOS:000373072800141

Cite this

@article{f8583cbb42f54f828206dde79391851a,

title = "Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinities",

author = "Domogalla, {M. P.} and Frick, {S. U.} and G. Baier and F. Wurm and V. Mailaender and K. Landfester and K. Steinbrink",

year = "2016",

month = mar,

doi = "10.1111/exd.12952",

language = "English",

volume = "25",

pages = "E24",

journal = "Experimental dermatology",

issn = "0906-6705",

publisher = "Wiley-Blackwell",

number = "3",

}

Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinities. / Domogalla, M. P.; Frick, S. U.; Baier, G.; Wurm, F.; Mailaender, V.; Landfester, K.; Steinbrink, K.

In: Experimental dermatology, Vol. 25, No. 3, P140, 03.2016, p. E24.

Research output: Contribution to journal › Conference article › Academic › peer-review

TY - JOUR

T1 - Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinities

AU - Domogalla, M. P.

AU - Frick, S. U.

AU - Baier, G.

AU - Wurm, F.

AU - Mailaender, V.

AU - Landfester, K.

AU - Steinbrink, K.

PY - 2016/3

Y1 - 2016/3

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000373072800141&KeyUID=WOS:000373072800141

U2 - 10.1111/exd.12952

DO - 10.1111/exd.12952

M3 - Conference article

VL - 25

SP - E24

JO - Experimental dermatology

JF - Experimental dermatology

SN - 0906-6705

IS - 3

M1 - P140

ER -